Business Context and Reporting Period
Company: Anthem, Inc. (now Elevance Health, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: May 12, 2017
Subject: Termination of the proposed acquisition of Cigna Corporation.
Key Financial Metrics
This filing is a current report regarding a material definitive agreement termination and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metrics.
Material Changes
- Merger Termination: On May 12, 2017, Anthem delivered a notice to Cigna terminating the Agreement and Plan of Merger dated July 23, 2015.
- Legal Preceding Events:
- On April 28, 2017, the U.S. Circuit Court of Appeals for the District of Columbia affirmed a ruling blocking the acquisition.
- On May 11, 2017, the Delaware Court of Chancery denied Anthem's motion for a preliminary injunction to stop Cigna from terminating the agreement, though it stayed the ruling pending Anthem's decision on an appeal.
Outlook, Risks, and Management Commentary
Management Action: Following the Delaware Court of Chancery's denial of the preliminary injunction, management elected to terminate the Merger Agreement rather than pursue an appeal at that time.
Disclosure: A press release was issued on May 12, 2017, detailing the termination (furnished as Exhibit 99.1).
Risks: The filing highlights the legal risk of regulatory and judicial intervention blocking major M&A transactions.
Investor Verification Checklist
- Verify the final status of the Delaware Court of Chancery stay and whether Anthem pursued an appeal after the May 12 termination notice.
- Review the press release (Exhibit 99.1) for any specific financial penalties or breakup fees associated with the termination.
- Confirm the impact of the terminated merger on Anthem's strategic growth plans and future capital allocation.
- Check subsequent filings for any updated guidance or operational changes resulting from the failed acquisition.